Related Experiment Video

Updated: May 29, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges

Laura E MacConaill1, Paul Van Hummelen, Matthew Meyerson

  • 1Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA.

Cancer Discovery
|September 22, 2011
PubMed

Insights

Targeting specific mutant proteins with anticancer therapies requires comprehensive cancer genome analysis. Identifying patients with specific genetic alterations ensures they receive the most effective treatments.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Targeted anticancer therapies are increasingly developed for specific mutant proteins.
  • Patient selection based on tumor genetic alterations improves therapeutic efficacy.
  • Comprehensive cancer genome characterization is crucial for personalized medicine.

Purpose of the Study:

  • To review the current state of cancer genome analysis.
  • To discuss the implementation of genomic technologies in clinical settings.
  • To highlight challenges and opportunities in clinical cancer genomics.

Main Methods:

  • Review of current technologies for genomic analysis.
  • Discussion of data interpretation and clinical application.

Main Results:

  • Genomic analysis technologies have advanced significantly.
  • Comprehensive cancer genome analysis is feasible.
  • Clinical implementation faces challenges but offers opportunities.

Conclusions:

  • Personalized cancer treatment relies on understanding individual tumor genomics.
  • Advanced genomic technologies are essential for identifying optimal therapies.
  • Bridging genomic research and clinical practice is key for future cancer care.

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues10:41

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...